Tin tức & Cập nhật

Nivolumab plus chemo offers prolonged survival in resectable NSCLC
Nivolumab plus chemo offers prolonged survival in resectable NSCLC
14 Jun 2024 bởiStephen Padilla

Patients with resectable nonsmall cell lung cancer (NSCLC) enjoy sustained survival from neoadjuvant nivolumab when added to chemotherapy compared with chemotherapy alone, as seen in the 4-year analysis from the phase III CheckMate 816 study.

Nivolumab plus chemo offers prolonged survival in resectable NSCLC
14 Jun 2024
COVID-19 does mess with the brain even years after infection
COVID-19 does mess with the brain even years after infection
06 Jun 2024 bởiAudrey Abella

A long-term study showed that individuals who have recovered from COVID-19 continued to experience cognitive, psychiatric, and neurological issues, as well as brain functional alteration, even 2 years after being infected.

COVID-19 does mess with the brain even years after infection
06 Jun 2024
FMT eases anxiety, sleep disturbance in postacute COVID-19 syndrome patients
FMT eases anxiety, sleep disturbance in postacute COVID-19 syndrome patients
05 Jun 2024 bởiStephen Padilla

Patients with postacute COVID-19 syndrome (PACS) may benefit from faecal microbiota transplantation (FMT) treatment, which helps reduce anxiety and improve sleep quality, suggests a study.

FMT eases anxiety, sleep disturbance in postacute COVID-19 syndrome patients
05 Jun 2024
SABA overused, increases all-cause mortality among HK asthma patients
SABA overused, increases all-cause mortality among HK asthma patients
01 Jun 2024 bởiNatalia Reoutova

Overuse of short-acting β2 agonists (SABA) is prevalent among patients with asthma in Hong Kong and associated with an increased risk of all-cause mortality and hospital admissions, according to a local retrospective cohort study, which was part of the global SABINA (SABA Use in Asthma) research programme.

SABA overused, increases all-cause mortality among HK asthma patients
01 Jun 2024